Local effects of the sphingosine 1-phosphate on prostaglandin F2alpha-induced luteolysis in the pregnant rat

Molecular Reproduction and Development

Volumn 76, Issue 12, 2009, Pages 1153-1164

  Hernandez, Fatima ^a   Peluffo, Marina C ^b   Bas, Diana ^a   Stouffer, Richard L ^b   Tesone, Marta ^a,c  

^a Universidad Nacional de Río Cuarto Consejo Nacional de Investigaciones Científicas y Técnicas   (Argentina)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 2; CASPASE 8; CASPASE 9; PROGESTERONE; PROSTAGLANDIN F2 ALPHA; PROTEIN KINASE B; SPHINGOSINE 1 PHOSPHATE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; CORPUS LUTEUM; DRUG EFFECT; ELECTRON MICROSCOPY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; LUTEOLYSIS; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT;

RATTUS;

EID: 70350439433     PISSN: 1040452X     EISSN: 10982795     Source Type: Journal    
DOI: 10.1002/mrd.21083     Document Type: Article

References (91)

1. Abdo MA, Richards A, Atiya N, Singh B, Parkinson S, Hisheh S, Dharmarajan AM. 2001. Inhibitors of caspase homologues suppress an apoptotic phenotype in cultured rabbit corpora lutea. Reprod Fertil Dev 13:395-403. (Pubitemid 34041455)
2. Abdo M, Hisheh S, Dharmarajan A. 2003. Role of tumor necrosis factor-alpha and the modulating effect of the caspases in rat corpus luteum apoptosis. Biol Reprod 68:1241-1248. (Pubitemid 36359112)
3. Abramovich D, Parborell F, Tesone M. 2006. Effect of a vascular endothelial growth factor (VEGF) inhibitory treatment on the folliculogenesis and ovarian apoptosis in gonadotropin-treated prepubertal rats. Biol Reprod 75:434-441. (Pubitemid 44268078)
4. Abramovich D, Irusta G, Parborell F, Tesone M. 2009. Intrabursal injection of vascular endothelial growth factor trap in eCG-treated prepubertal rats inhibits proliferation and increases apoptosis of follicular cells involving the PI3K/AKT signaling pathway. Fertil Steril Mar 26 [Epub ahead of print] PMID: 19328472l.
5. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J. 1996. Human ICE/CED-3 protease nomenclature. Cell 87:171.
6. Alvarez SE, Milstien S, Spiegel S. 2007. Autocrine and paracrine roles of sphingosine-1-phosphate. Trends Endocrinol Metab 18:300-307.
7. Andreu C, Parborell F, Vanzulli S, Chemes H, Tesone M. 1998. Regulation of follicular luteinization by a gonadotropin-releasing hormone agonist: Relationship between steroidogenesis and apoptosis. Mol Reprod Dev 51:287-294. (Pubitemid 28445409)
8. Bacci ML, Barazzoni AM, Forni M, Costerbosa GL. 1996. In situ detection of apoptosis in regressing corpus luteum of pregnant sow: Evidence of an early presence of DNA fragmentation. Domest Anim Endocrinol 13:361-372.
9. Balthasar S, Bergelin N, Lof C, Vainio M, Andersson S, Tornquist K. 2008. Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells. Endocr Relat Cancer 15:521-534. (Pubitemid 351880840)
10. Beg AA, Baltimore D. 1996. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 274:782-784. (Pubitemid 26398258)
11. Boone DL, Tsang BK. 1998. Caspase-3 in the rat ovary: Localization and possible role in follicular atresia and luteal regression. Biol Reprod 58:1533-1539.
12. Bowen J, Keyes P, Warren J, Townson D. 1996. Prolactin-induced regression of the rat corpus luteum: Expression of monocyte chemoattractant protein-1 and invasion of macrophages. Biol Reprod 54:1120-1127. (Pubitemid 26126758)
13. Bowen-Shauver JM, Gibori G. 2004. The corpus luteum of pregnancy. In: Adashi EY, Leung PCK, editors. The Ovary. San Diego: Elsevier Inc, Academic Press. p 201-230.
14. Brannstrom M, Friden B. 1997. Immune regulation of corpus luteum function. Semin Reprod Endocrinol 15:363-370. (Pubitemid 28166411)
15. Bussmann LE. 1989. Prostaglandin F-2 alpha receptors in corpora lutea of pregnant rats and relationship with induction of 20 alpha-hydroxysteroid dehydrogenase. J Reprod Fertil 85:331-341.
16. Carambula SF, Pru JK, Lynch MP, Matikainen T, Goncalves PB, Flavell RA, Tilly JL, Rueda BR. 2003. Prostaglandin F2alpha- and FAS-activating antibody-induced regression of the corpus luteum involves caspase-8 and is defective in caspase-3 deficient mice. Reprod Biol Endocrinol 1:15. (Pubitemid 39130509)
17. Chae SS, Proia RL, Hla T. 2004. Constitutive expression of the S1P1 receptor in adult tissues. Prostaglandins Other Lipid Mediat 73:141-150. (Pubitemid 38446477)
18. Channing CP. 1969a. Steroidogenesis and morphology of human ovarian cell types in tissue culture. J Endocrinol 45:297-308.
19. Channing CP. 1969b. Tissue culture of equine ovarian cell types: Culture methods and morphology. J Endocrinol 43:381-390.
20. Chinnaiyan AM, Dixit VM. 1996. The cell-death machine. Curr Biol 6:555-562.
21. Cryns V, Yuan J. 1998. Proteases to die for. Genes Dev 12:1551-1570.
22. Cuvillier O, Levade T. 2001. Sphingosine 1-phosphate antagonizes apoptosis of human leukemia cells by inhibiting release of cytochrome c and Smac/DIABLO from mitochondria. Blood 98:2828-2836.
23. Cuvillier O, Pirianov G, Kleuser B, Vanek PG, Coso OA, Gutkind S, Spiegel S. 1996. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381:800-803. (Pubitemid 26243122)
24. Davis JS, Rueda BR. 2002. The corpus luteum: An ovarian structure with maternal instincts and suicidal tendencies. Front Biosci 7:d1949-d1978.
25. DeLisser HM, Newman PJ, Albelda SM. 1993. Platelet endothelial cell adhesion molecule (CD31). Curr Top Microbiol Immunol 184:37-45.
26. Engelman JA, Luo J, Cantley LC. 2006. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7:606-619. (Pubitemid 44100518)
27. Ferrara N, Damico L, Shams N, Lowman H, Kim R. 2006. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Retina 26:859-870. (Pubitemid 44547437)
28. Friedman A, Weiss S, Levy N, Meidan R. 2000. Role of tumor necrosis factor alpha and its type I receptor in luteal regression: Induction of programmed cell death in bovine corpus luteum-derived endothelial cells. Biol Reprod 63:1905-1912. (Pubitemid 30954204)
29. Gao N, Zhang Z, Jiang BH, Shi X. 2003. Role of PI3K/AKT/mTOR signaling in the cell cycle progression of human prostate cancer. Biochem Biophys Res Commun 310:1124-1132. (Pubitemid 37237653)
30. Gao N, Flynn DC, Zhang Z, Zhong XS, Walker V, Liu KJ, Shi X, Jiang BH. 2004. G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells. Am J Physiol Cell Physiol 287:C281-C291. (Pubitemid 38955218)
31. Gaytan F, Bellido C, Morales C, Sanchez-Criado JE. 1998. Both prolactin and progesterone in proestrus are necessary for the induction of apoptosis in the regressing corpus luteum of the rat. Biol Reprod 59:1200-1206. (Pubitemid 28498933)
32. Goodman SB, Kugu K, Chen SH, Preutthipan S, Tilly KI, Tilly JL, Dharmarajan AM. 1998. Estradiol-mediated suppression of apoptosis in the rabbit corpus luteum is associated with a shift in expression of bcl-2 family members favoring cellular survival. Biol Reprod 59:820-827. (Pubitemid 28463333)
33. Goyeneche AA, Harmon JM, Telleria CM. 2006. Cell death induced by serum deprivation in luteal cells involves the intrinsic pathway of apoptosis. Reproduction 131:103-111.
34. Guo K, Wolf V, Dharmarajan AM, Feng Z, Bielke W, Saurer S, Friis R. 1998. Apoptosis-associated gene expression in the corpus luteum of the rat. Biol Reprod 58:739-746. (Pubitemid 28117072)
35. Guo Y, Srinivasula SM, Druilhe A, Fernandes-Alnemri T, Alnemri ES. 2002. Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria. J Biol Chem 277:13430-13437. (Pubitemid 34967937)
36. Hancke K, Strauch O, Kissel C, Gobel H, Schafer W, Denschlag D. 2007. Sphingosine 1-phosphate protects ovaries from chemotherapy-induced damage in vivo. Fertil Steril 87:172-177. (Pubitemid 46013885)
37. Hansel W, Blair RM. 1996. Bovine corpus luteum: A historic overview and implications for future research. Theriogenology 45:1267-1294. (Pubitemid 126653047)
38. Hasumoto K, Sugimoto Y, Yamasaki A, Morimoto K, Kakizuka A, Negishi M, Ichikawa A. 1997. Association of expression of mRNA encoding the PGF2 alpha receptor with luteal cell apoptosis in ovaries of pseudopregnant mice. J Reprod Fertil 109:45-51. (Pubitemid 27089482)
39. Hazzard TM, Stouffer RL. 2000. Angiogenesis in ovarian follicular and luteal development. Baillieres Best Pract Res Clin Obstet Gynaecol 14:883-900.
40. Henkes LE, Sullivan BT, Lynch MP, Kolesnick R, Arsenault D, Puder M, Davis JS, Rueda BR. 2008. Acid sphingomyelinase involvement in tumor necrosis factor alpha-regulated vascular and steroid disruption during luteolysis in vivo. Proc Natl Acad Sci USA 105:7670-7675. (Pubitemid 351872696)
41. Hong G, Baudhuin LM, Xu Y. 1999. Sphingosine-1-phosphate modulates growth and adhesion of ovarian cancer cells. FEBS Lett 460:513-518. (Pubitemid 29518430)
42. Igarashi J, Erwin PA, Dantas AP, Chen H, Michel T. 2003. VEGF induces S1P1 receptors in endothelial cells: Implications for cross-talk between sphingolipid and growth factor receptors. Proc Natl Acad Sci USA 100:10664-10669. (Pubitemid 37140085)
43. Irusta G, Parborell F, Peluffo M, Manna PR, Gonzalez-Calvar SI, Calandra R, Stocco DM, Tesone M. 2003. Steroidogenic acute regulatory protein in ovarian follicles of gonadotropin-stimulated rats is regulated by a gonadotropin- releasing hormone agonist. Biol Reprod 68:1577-1583. (Pubitemid 36519760)
44. Jiang BH, Liu LZ. 2008. PI3K/PTEN signaling in tumorigenesis and angiogenesis. Biochim Biophys Acta 1784:150-158.
45. Khan SM, Dauffenbach LM, Yeh J. 2000. Mitochondria and caspases in induced apoptosis in human luteinized granulosa cells. Biochem Biophys Res Commun 269:542-545. (Pubitemid 30440337)
46. Koos RD. 1993. Ovarian angiogenesis. In: Adashi EY, Leung PCK, editors. The Ovary. San Diego: Elsevier, Academic Press. p 433-453.
47. Krajewska M, Wang HG, Krajewski S, Zapata JM, Shabaik A, Gascoyne R, Reed JC. 1997. Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease. Cancer Res 57:1605-1613. (Pubitemid 27175582)
48. Kuranaga E, Kanuka H, Bannai M, Suzuki M, Nishihara M, Takahashi M. 1999. Fas/Fas ligand system in prolactin-induced apoptosis in rat corpus luteum: Possible role of luteal immune cells. Biochem Biophys Res Commun 260:167-173. (Pubitemid 29351802)
49. Liszewska E, Rekawiecki R, Kotwica J. 2005. Effect of progesterone on the expression of bax and bcl-2 and on caspase activity in bovine luteal cells. Prostaglandins Other Lipid Mediat 78:67-81. (Pubitemid 41636834)
50. Maines LW, French KJ, Wolpert EB, Antonetti DA, Smith CD. 2006. Pharmacologic manipulation of sphingosine kinase in retinal endothelial cells: Implications for angiogenic ocular diseases. Invest Ophthalmol Vis Sci 47:5022-5031.
51. Martin SJ, Green DR. 1995. Protease activation during apoptosis: Death by a thousand cuts? Cell 82:349-352.
52. May MJ, Ghosh S. 1999. IkappaB kinases: Kinsmen with different crafts. Science 284:271-273. (Pubitemid 129523437)
53. Milvae RA, Hinckley ST, Carlson JC. 1996. Luteotropic and luteolytic mechanisms in the bovine corpus luteum. Theriogenology 45:1327-1349. (Pubitemid 126653049)
54. Morita Y, Perez GI, Paris F, Miranda SR, Ehleiter D, Haimovitz- Friedman A, Fuks Z, Xie Z, Reed JC, Schuchman EH, Kolesnick RN, Tilly JL. 2000. Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat Med 6:1109-1114. (Pubitemid 30792189)
55. Nicholson DW. 1999. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ 6:1028-1042.
56. Niswender GD, Nett TM. 1994. Corpus luteum and its control in infraprimate species. In: Knobil E, Neil JD, editors. The Physiology of Reproduction. New York: Raven Press. p 781-816.
57. Osawa Y, Banno Y, Nagaki M, Brenner DA, Naiki T, Nozawa Y, Nakashima S, Moriwaki H. 2001. TNF-alpha-induced sphingosine 1-phosphate inhibits apoptosis through a phosphatidylinositol 3-kinase/Akt pathway in human hepatocytes. J Immunol 167:173-180. (Pubitemid 32567775)
58. Oyama O, Sugimoto N, Qi X, Takuwa N, Mizugishi K, Koizumi J, Takuwa Y. 2008. The lysophospholipid mediator sphingosine-1-phosphate promotes angiogenesis in vivo in ischaemic hindlimbs of mice. Cardiovasc Res 78:301-307. (Pubitemid 351556099)
59. Papadopoulos V, Dharmarajan AM, Li H, Culty M, Lemay M, Sridaran R. 1999. Mitochondrial peripheral-type benzodiazepine receptor expression. Correlation with gonadotropin-releasing hormone (GnRH) agonist-induced apoptosis in the corpus luteum. Biochem Pharmacol 58:1389-1393.
60. Parborell F, Abramovich D, Tesone M. 2008. Intrabursal administration of the antiangiopoietin 1 antibody produces a delay in rat follicular development associated with an increase in ovarian apoptosis mediated by changes in the expression of BCL2 related genes. Biol Reprod 78:506-513.
61. Payne SG, Milstien S, Spiegel S. 2002. Sphingosine-1-phosphate: Dual messenger functions. FEBS Lett 531:54-57.
62. Peluffo MC, Young KA, Stouffer RL. 2005. Dynamic expression of caspase-2, -3, -8, and -9 proteins and enzyme activity, but not messenger ribonucleic acid, in the monkey corpus luteum during the menstrual cycle. J Clin Endocrinol Metab 90:2327-2335.
63. Peluffo MC, Bussmann L, Stouffer RL, Tesone M. 2006. Expression of caspase-2, -3, -8 and -9 proteins and enzyme activity in the corpus luteum of the rat at different stages during the natural estrous cycle. Reproduction 132:465-475. (Pubitemid 44524510)
64. Peluffo MC, Stouffer RL, Tesone M. 2007. Activity and expression of different members of the caspase family in the rat corpus luteum during pregnancy and postpartum. Am J Physiol Endocrinol Metab 293:E1215-E1223. (Pubitemid 350106587)
65. Petroff MG, Petroff BK, Pate JL. 1999. Expression of cytokine messenger ribonucleic acids in the bovine corpus luteum. Endocrinology 140:1018-1021.
66. Pharriss B. 1971. Prostaglandin induction of luteolysis. Ann NY Acad Sci 180:436-444.
67. Pharriss BB, Wyngarden LJ. 1969. The effect of prostaglandin F 2alpha on the progestogen content of ovaries from pseudopregnant rats. Proc Soc Exp Biol Med 130:92-94.
68. Pharriss BB, Tillson SA, Erickson RR. 1972. Prostaglandins in luteal function. Recent Prog Horm Res 28:51-89.
69. Pru JK, Hendry IR, Davis JS, Rueda BR. 2002. Soluble Fas ligand activates the sphingomyelin pathway and induces apoptosis in luteal steroidogenic cells independently of stress-activated p38-(MAPK). Endocrinology 143:4350-4357.
70. Reynolds ES. 1963. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J Cell Biol 17:208-212.
71. Rueda BR, Hendry IR, Tilly JL, Hamernik DL. 1999. Accumulation of caspase-3 messenger ribonucleic acid and induction of caspase activity in the ovine corpus luteum following prostaglandin F2alpha treatment in vivo. Biol Reprod 60:1087-1092.
72. Sanchez T, Hla T. 2004. Structural and functional characteristics of S1P receptors. J Cell Biochem 92:913-922. (Pubitemid 44264241)
73. Sanchez T, Skoura A, Wu MT, Casserly B, Harrington EO, Hla T. 2007. Induction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN. Arterioscler Thromb Vasc Biol 27:1312-1318. (Pubitemid 46809419)
74. Schwartz BM, Hong G, Morrison BH, Wu W, Baudhuin LM, Xiao YJ, Mok SC, Xu Y. 2001. Lysophospholipids increase interleukin-8 expression in ovarian cancer cells. Gynecol Oncol 81:291-300. (Pubitemid 32424177)
75. Spiegel S, Milstien S. 2000. Sphingosine-1-phosphate: Signaling inside and out. FEBS Lett 476:55-57.
76. Spiegel S, Milstien S. 2003a. Exogenous and intracellularly generated sphingosine 1-phosphate can regulate cellular processes by divergent pathways. Biochem Soc Trans 31:1216-1219. (Pubitemid 38030942)
77. Spiegel S, Milstien S. 2003b. Sphingosine-1-phosphate: An enigmatic signalling lipid. Nat Rev Mol Cell Biol 4:397-407.
78. Stocco C, Telleria C, Gibori G. 2007. The molecular control of corpus luteum formation, function, and regression. Endocr Rev 28:117-149. (Pubitemid 46220852)
79. Stouffer RL. 2004. The function and regulation of cell populations comprising the corpus luteum during the ovarian cycle. In: Adashi EY, Leung PCK, editors. The Ovary. San Diego: Elsevier, Academic Press. p 169-184.
80. Telleria CM, Goyeneche AA, Cavicchia JC, Stati AO, Deis RP. 2001. Apoptosis induced by antigestagen RU486 in rat corpus luteum of pregnancy. Endocrine 15:147-155.
81. Terranova PF, Rice VM. 1997. Review: Cytokine involvement in ovarian processes. Am J Reprod Immunol 37:50-63.
82. Thornberry NA, Lazebnik Y. 1998. Caspases: Enemies within. Science 281:1312-1316.
83. Wang CY, Mayo MW, Baldwin AS, Jr. 1996. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-kappaB. Science 274:784-787.
84. Wu M, Lee H, Bellas RE, Schauer SL, Arsura M, Katz D, FitzGerald MJ, Rothstein TL, Sherr DH, Sonenshein GE. 1996. Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells. EMBO J 15:4682-4690. (Pubitemid 26294586)
85. Xia P, Gamble JR, Rye KA, Wang L, Hii CS, Cockerill P, Khew- Goodall Y, Bert AG, Barter PJ, Vadas MA. 1998. Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway. Proc Natl Acad Sci USA 95:14196-14201. (Pubitemid 28549344)
86. Xia P, Wang L, Gamble JR, Vadas MA. 1999. Activation of sphingosine kinase by tumor necrosis factor-alpha inhibits apoptosis in human endothelial cells. J Biol Chem 274:34499-34505. (Pubitemid 129511798)
87. Xu Y, Fang XJ, Casey G, Mills GB. 1995. Lysophospholipids activate ovarian and breast cancer cells. Biochem J 309:933-940.
88. Xu Y, Shen Z, Wiper DW, Wu M, Morton RE, Elson P, Kennedy AW, Belinson J, Markman M, Casey G. 1998. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA 280:719-723. (Pubitemid 28405297)
89. Xu Y, Xiao YJ, Baudhuin LM, Schwartz BM. 2001. The role and clinical applications of bioactive lysolipids in ovarian cancer. J Soc Gynecol Invest 8:1-13.
90. Yadav VK, Lakshmi G, Medhamurthy R. 2005. Prostaglandin F2alpha-mediated activation of apoptotic signaling cascades in the corpus luteum during apoptosis: Involvement of caspase-activated DNase. J Biol Chem 280:10357-10367. (Pubitemid 40395892)
91. Zhao Y, Burbach JA, Roby KF, Terranova PF, Brannian JD. 1998. Macrophages are the major source of tumor necrosis factor alpha in the porcine corpus luteum. Biol Reprod 59:1385-1391. (Pubitemid 28549853)